Archives

The Global Forum on TB Vaccines will take place from 8-10 October 2024 and will be hosted in Rio de Janeiro, Brazil. The Call for Abstracts for the 7th Global Forum on TB Vaccines is now [...]

World Tuberculosis Day serves as a poignant reminder to raise awareness about tuberculosis (TB). Despite the efforts and promising developments in the fight against this disease, TB remains an [...]

MTBVAC, the Spanish tuberculosis vaccine, the first live attenuated vaccine of Mycobacterium tuberculosis isolated from a human, reaches a new milestone by starting clinical trials in India, the [...]

The Bill & Melinda Gates Medical Research Institute (Gates MRI) today (19 March 2024) announced that a Phase 3 clinical trial to assess the efficacy of the M72/AS01E tuberculosis (TB) vaccine [...]

March 2024 – The TBVI Governance Board is pleased to announce the appointment of a new Executive Director of the organisation. Tuberculosis (TB) stands as one of the most persistent and [...]

On January 30-31, 2024, the TBVI Symposium was held in Les Diablerets, Switzerland. This year, the symposium brought together over 120 tuberculosis (TB) vaccine researchers, developers, funders [...]

Please find below the Programme TBVI Symposium 2024  for the TBVI symposium 2024, which will be held on January 30 and 31, 2024 in Les Diablerets. Tuesday January 30, 2024 (Maison des congrès) [...]

The TBVI team wishes you and your loved ones a joyful holiday season. May the New Year bring you renewed hope, good health and happiness.    We want to express our heartfelt gratitude to all [...]

To encourage talented young scientists and recognise outstanding contributions to TB vaccine research and development, in October TBVI published the TBVI Young Scientist Awards 2024. It is our [...]

The Working Group on New TB Vaccines (WGNV), IAVI, and the TuBerculosis Vaccine Initiative (TBVI), in partnership with the Ministry of Health of Brazil and the Brazilian TB Research Network [...]